Analysis of signal transduction mechanism through a novel tyrosine kinase receptor
Analysis of signal transduction mechanism through a novel tyrosine kinase receptor
批准号:
03454521
负责人:
HIRAI Hisamaru
金额:
$3.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992
中文摘要
此前,我们通过与c-FMS探针的低严格杂交,从人红白血病细胞系K562的cDNA库中克隆了一个ltk基因。为获得人胎盘全长cDNA,对人胎盘基因文库进行了筛选,获得了5个阳性克隆。其中一个克隆(P2)含有最长的开放阅读框,编码一个由864个氨基酸组成的酪氨酸激酶受体。对这5个克隆的分析表明,至少有3个克隆存在。其中一个cdna预测了一个221个氨基酸的蛋白质,并编码了一种可从细胞分泌的可溶性受体。另一个克隆(P3)在跨膜区下游有一个可选择的插入片段,因此在跨膜区和酪氨酸激酶结构域之间产生了框内终止密码子,这表明该克隆编码的是一个缺乏激活域的受体蛋白。我们将含有不同ltk cdna克隆的表达载体导入cos细胞,细胞裂解产物为亚…。更多地受到西方印迹分析的影响。抗P2和P3细胞裂解物中分别检测到约100kD和50kD的蛋白质。这两种产物都显示为双条带,这可能是翻译后修饰的结果。这些结果表明,这些cDNA并不代表未成熟的未剪接的前mRNAs。表达完整的ltk cdna克隆的COS细胞裂解产物免疫复合物在体外用[Gamma-^<;32>;P]ATPase检测。实验中检测到100kD、140kD、85kD和45kD蛋白的磷酸化,表明LtK蛋白具有蛋白激酶活性,并对自身和其他相关蛋白进行磷酸化。我们已经在抗Ltk抗体沉淀的免疫复合体中检测到PLC-Gamma1、GAP、PI3-激酶和c-RAF蛋白。在35例人类恶性肿瘤的Northern印迹分析中,ltk基因在白血病(10/18例)中优先表达,但在17例非白血病肿瘤中均不表达。较少
英文摘要
Previously, we cloned an ltk cDNA isolated from a human erythroleukemia cell line K562 cDNA library by low stringency hybridization with a c-fms probe. To obtain a full length cDNA, a cDNA library of human placenta was screened, and five positive clones were isolated. One clone (P2) contains the longest open reading frame which encodes a putative tyrosine kinase receptor of 864 amino acids. The analysis of the five clones revealed the existence of at least three spieces of cDNA clones. One cDNA predicts a protein of 221 amino acids and encodes a soluble type of receptor which can be secreted from the cell. Another cDNA clone (P3) has an alternative insert just downstream of the transmembrane domain and thus produce in-frame stop codon between the transmembrane domain and the tyrosine kinase domain, suggesting that this clone encodes a receptor protein lacking the kinase domain. We transfected expression plasmids containing various ltk cDNA clones to COS cells, and cell lysates were sub … More jected to western blot analysis. Proteins of approximately 100kD and 50kD were detected by the monoclonal antibody against the extracellular domain in the cell lysates transfected with P2 and P3, respectively. Both products are shown in double bands which may result from posttranslational modification. These results suggest that these cDNAs do not represent immature unspliced pre-mRNAs. Immune complexes from lysates of COS cells expressing the full ltk cDNA clone were subjected to in vitro kinase assay using [gamma-^<32>P]ATP. Phosphorylation of 100kD, 140kD, 85kD and 45kD proteins was detected in the experiment, suggesting that ltk protein has protein kinase activity and phosphorylates itself and other associated proteins. We have detected PLC-gamma1, GAP, PI3-kinase, and c-raf protein in the immune complex precipitated by anti-ltk antibody. In Northern blot analysis of 35 human malignancies, ltk is preferentially expressed in leukemias (10 out of 18 cases) with no cell lineage specificity, but none of 17 nonleukemic neoplasms expressed ltk gene. Less
期刊论文(47)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hanazono Y, Chiba S, Sasaki K, Mano H, Miyajima A, Arai K, Yazaki Y, Hirai H.: "c-fpslfes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3." EMBO J.
Hanazono Y、Chiba S、Sasaki K、Mano H、Miyajima A、Arai K、Yazaki Y、Hirai H.:“c-fpslfes 蛋白酪氨酸激酶参与粒细胞巨噬细胞集落刺激因子和白细胞介素触发的信号通路
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Chiba S,et al.: "Establishment and erythroid differentiation of a cytoーkineーdependent human leukemic cell line F36:A parental line requiring granulocyteーmacrophage colonyーstimulating factor or interleukin ー3,and a subline requiring erythropoietin." Blood.
Chiba S 等人:“细胞因子依赖性人白血病细胞系 F36 的建立和红系分化:需要细胞巨噬细胞集落刺激因子或白细胞介素 3 的亲本系,以及需要促红细胞生成素的亚系。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sugimoto K,et al.: "Frequent mutations in the p53 gene in human myeloid leukemia cell lines." Blood.
Sugimoto K 等人:“人骨髓性白血病细胞系中 p53 基因的频繁突变。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Toyoshima H et al.: "Differently spliced cDNAs of human ltk receptor tyrosine leinase predict receptor proteins with and without tyrosine leinase sowain and a sdubli receptor protein." Proc.Nael.Acad.Sci.USA.
Toyoshima H 等人:“人类 ltk 受体酪氨酸酶的不同剪接 cDNA 可以预测有或没有酪氨酸酶 sowain 和 sdubli 受体蛋白的受体蛋白。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Hirai H, Ishikawa F, Takaku F.: "Mutations of the p53 gene in lymphoid leukemia." Blood. 77. 1153-1156 (1991)
Sugimoto K、Toyoshima H、Sakai R、Miyakawa K、Hagiwara K、Hirai H、Ishikawa F、Takaku F.:“淋巴细胞白血病中 p53 基因的突变。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 32 条
Analyses of Maltipotential Functions of a Novel Signaling Molecule, Cas
-
批准号:11694250
-
项目类别:Grant-in-Aid for Scientific Research (A).
-
资助金额:$5.57万
-
财政年份:1999
-
负责人:HIRAI Hisamaru
-
依托单位:
Practical development of a novel method for hematopoietic stem cell expansion
-
批准号:09357010
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$18.24万
-
财政年份:1997
-
负责人:HIRAI Hisamaru
-
依托单位:
Analyses of a Novel Signaling Molecule, Cas
-
批准号:09044271
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$5.44万
-
财政年份:1997
-
负责人:HIRAI Hisamaru
-
依托单位:
Analysis of molecular mechanisms of leukemia development
-
批准号:09307021
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$24.58万
-
财政年份:1997
-
负责人:HIRAI Hisamaru
-
依托单位:
Analysis of Molecular Mechanism of Blastic Crisis in Chronic Myelocytic Leukemia
-
批准号:07042002
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.65万
-
财政年份:1995
-
负责人:HIRAI Hisamaru
-
依托单位:
Functional analysis of AML1 gene in normal hematopoietic cells and leukemia cells
-
批准号:07457229
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.48万
-
财政年份:1995
-
负责人:HIRAI Hisamaru
-
依托单位:
Molecular analysis of leukemias with chromosomal translocation and its application for clinical Diagnosis
-
批准号:05454328
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.1万
-
财政年份:1993
-
负责人:HIRAI Hisamaru
-
依托单位:
Molecular Diagnosis of Human Leukemias
-
批准号:04253208
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$12.16万
-
财政年份:1992
-
负责人:HIRAI Hisamaru
-
依托单位:
Development and clinical application of molecular diagnosis in leukemias
-
批准号:04557133
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$9.73万
-
财政年份:1992
-
负责人:HIRAI Hisamaru
-
依托单位:
海外基金